Drug Combo Improves Recurrence-Free Survival After HCC Resection Drug Combo Improves Recurrence-Free Survival After HCC Resection

The atezolizumab-bevacizumab combination is the first to show efficacy in the adjuvant setting after HCC resection for patients at high risk for recurrence, but the overall survival benefit is unclear.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news